Quick Answer: Hidradenitis suppurativa’s real evidence base for light-based treatment is photodynamic therapy (PDT) — a photosensitizing drug like ALA or MAL applied to the skin and then activated with light in a clinical setting — not a standalone home red light panel. A systematic review of 18 studies found red-light PDT with 16% MAL showed only modest benefit from a small number of poor-quality, high-bias studies (Grade C, Level III evidence), while the best-performing light-based approach, 1-5% ALA with an intralesional diode laser, hit a 78-94% response rate (Grade B, Level II evidence) — both clinician-applied drug-plus-laser procedures. The actual FDA-approved standard treatments are biologics (Humira, Cosentyx), antibiotics, and surgery. A home panel like the Hooga HG300 (about $199) has no clinical trial behind it for HS specifically and should be treated as a general-inflammation supplement at best, never a replacement for dermatologic care.
Hidradenitis suppurativa (HS) is a chronic, painful inflammatory skin condition — not acne, not an infection you caught from someone, and not something a wellness device is built to clear. It shows up as recurring nodules, abscesses, and eventually scarring tunnels in skin folds: armpits, groin, under the breasts, between the buttocks. Because red light therapy markets itself broadly across “inflammatory skin conditions,” it’s easy to assume it belongs on an HS treatment list. The research tells a more specific, less convenient story.
Hidradenitis suppurativa and light therapy, by the numbers
- HS affects roughly 1% of the population, with 2023 prevalence estimates putting the case count across major global markets at nearly 6.2 million people, the US alone accounting for about 2.88 million of that total.
- Only two biologics carry FDA approval for HS: adalimumab (Humira) and secukinumab (Cosentyx), with bimekizumab (Bimzelx) already approved in Europe and under US FDA review as of this guide’s last update — these are the actual evidence-backed drug treatments, not a light device.
- A systematic review covering 18 studies on laser and light-based HS treatments found red-light PDT with 16% methyl aminolevulinate showed only modest benefit, rated Grade C, Level III evidence — the review’s authors explicitly flagged small sample sizes, a lack of randomized controlled trials, and high risk of bias across the body of research.
- The most effective light-based approach found wasn’t a standalone light at all: 1-5% ALA photosensitizer combined with an intralesional diode laser produced a 78-94% good-to-complete response rate across treated sites, rated Grade B, Level II evidence — still a clinician-administered drug-plus-laser procedure, not a home panel.
Why “red light therapy for hidradenitis suppurativa” is a procedure mismatch
Every strong result in the HS light-therapy literature pairs light with a photosensitizing drug applied to the skin first — aminolevulinic acid (ALA) or methyl aminolevulinate (MAL) — then activates that drug with a specific wavelength to trigger a reactive-oxygen response that targets the affected follicles and glands. That’s photodynamic therapy (PDT), and it’s performed by a clinician who applies the drug, times the light exposure, and monitors the skin afterward. A home red or near-infrared panel — the kind reviewed throughout this site — delivers only the light half of that equation. Without the photosensitizer, there’s no equivalent mechanism being triggered, and no study on this page tested a plain panel against HS.
This is the same pattern covered in our dandruff guide and red vs blue light therapy comparison: the clinical evidence for a specific skin condition often depends on a drug-plus-light combination, while the consumer devices sold under the same “red light therapy” umbrella skip the drug entirely. For HS specifically, the gap matters more than usual, because the disease itself involves draining abscesses and tunneling under the skin — not a surface concern a general-purpose panel is positioned to address.
None of this means red/NIR light is harmful to try as a supplement. The broader anti-inflammatory mechanism behind red and near-infrared light, covered across this site’s other condition guides, plausibly calms some general inflammation on healing or unaffected skin nearby. It just isn’t the clinical PDT protocol the actual research tested, and it is not a substitute for the biologics, antibiotics, or surgical care that make up the real standard of treatment.
| Device | Best for | Wavelength | Price | Rating |
|---|---|---|---|---|
| Hooga HG300 | Best budget / general inflammation support | 660 / 850nm | ~$199 | ★★★★☆ |
| Mito Red Light MitoPRO 300+ | Best for a single affected area | 630 / 660 / 830 / 850nm | $369 | ★★★★☆ |
| Kineon MOVE+ Pro | Best wearable for a small skin-fold area | 660nm LED + 808nm laser | $499 | ★★★★☆ |
1. Hooga HG300 — Best Budget / General Inflammation Support
Hooga HG300 Red Light Therapy Panel
- Standard 660nm red and 850nm near-infrared LEDs, held a few inches from unaffected or healing skin nearby — never directly on an open or draining lesion.
- No clinical trial behind it for HS specifically; positioned here as general anti-inflammatory support, the same role it plays in our eczema guide.
- Doubles as a general-purpose panel for other body parts, which matters since HS devices have no dedicated product category.
- 3-year warranty and a 60-day in-home trial, per Hooga's own pricing.
Get your red light panel in two days — try Amazon Prime free for 30 days (sponsored) — useful if you want a panel on hand quickly while you’re also waiting on a dermatology referral.
The HG300 is the cheapest honest entry point if you want to try general red/NIR light on skin near an HS-affected area, with the clear caveat that it is not the PDT protocol the actual research tested. Treat it as a low-cost supplement to your real treatment plan, not a replacement for it.
2. Mito Red Light MitoPRO 300+ — Best for a Single Affected Area
Mito Red Light MitoPRO 300+
- Four wavelengths (630/660/830/850nm) rated over 130 mW/cm² at 6 inches on a professional spectroradiometer, per our full Mito Red Light review.
- 9" x 17" panel size suits a single underarm or groin-adjacent zone better than a full-body panel.
- FDA Class II registered and ETL certified, with a 3-year warranty and 60-day money-back trial — real regulatory and consumer-protection backing, though not an HS-specific clearance.
- Nearly double Hooga's price for higher measured output and two extra wavelengths, not for any added HS-specific evidence.
If you want a more premium panel sized for one specific area rather than a full-body session, the MitoPRO 300+ is the step up from the HG300 — more wavelengths and higher measured irradiance, same honest caveat that none of it has been tested on HS.
3. Kineon MOVE+ Pro — Best Wearable for a Small Skin-Fold Area
Kineon MOVE+ Pro
- Combines 660nm LED red light with an 808nm laser diode in a flexible pod, per our full Kineon review.
- Kineon says the laser reaches deeper tissue than LED-only panels, though that depth claim is relevant to muscle/joint use, not validated for HS.
- Small, curved form factor fits an armpit or groin-adjacent area better than a flat panel — a practical fit advantage, not a clinical one.
- At $499, this is the most expensive option here for a disease where the actual evidence-backed light treatment (PDT) isn't sold as a consumer product at any price.
The MOVE+ Pro’s curved, wearable shape is the most practical fit for an underarm or groin area out of the three devices here, but buy it for that practical reason — not because its laser depth claims have any HS-specific backing.
How to approach it
- See a dermatologist first, especially for active disease. Draining tunnels, recurring abscesses, and scarring are not a self-directed light-therapy situation — biologics, antibiotics, and surgical options are the actual standard of care.
- Understand that PDT is a different product from a home panel. The light-based research with real (if still limited) support used a photosensitizing drug applied by a clinician, not a standalone LED or laser device you buy on Amazon.
- If you try a home panel, use it as a supplement, not a substitute. General anti-inflammatory red/NIR light on unaffected or healing skin, alongside — never instead of — your dermatologist’s treatment plan, is the most defensible use case here.
- Never use a light device directly on an open, draining, or actively infected lesion. That’s a wound-care and medical-evaluation situation, the same line this site draws for burns and surgical scars.
If you came here hoping red light therapy was a proven HS treatment, the honest answer is that the strongest light-based evidence belongs to a clinical drug-plus-laser procedure most people will never buy as a consumer product. A home panel is, at best, a low-cost supplement to the real treatment — biologics, antibiotics, and surgery — not a replacement for it.
Red and near-infrared light devices are general wellness products, not medical treatments for hidradenitis suppurativa or any other diagnosed condition. This guide covers the hardware and the honest evidence, not medical advice — active or worsening HS should be evaluated and managed by a dermatologist. Prices and specs are manufacturer-stated and were verified against brand listings and this site’s own device canon in October 2026; prices change often.